1. Home
  2. VVOS vs HBIO Comparison

VVOS vs HBIO Comparison

Compare VVOS & HBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VVOS
  • HBIO
  • Stock Information
  • Founded
  • VVOS 2016
  • HBIO 1901
  • Country
  • VVOS United States
  • HBIO United States
  • Employees
  • VVOS N/A
  • HBIO N/A
  • Industry
  • VVOS Medical Specialities
  • HBIO Biotechnology: Laboratory Analytical Instruments
  • Sector
  • VVOS Health Care
  • HBIO Industrials
  • Exchange
  • VVOS Nasdaq
  • HBIO Nasdaq
  • Market Cap
  • VVOS 27.3M
  • HBIO 24.6M
  • IPO Year
  • VVOS 2020
  • HBIO 2000
  • Fundamental
  • Price
  • VVOS $3.47
  • HBIO $0.44
  • Analyst Decision
  • VVOS Strong Buy
  • HBIO Buy
  • Analyst Count
  • VVOS 2
  • HBIO 3
  • Target Price
  • VVOS $6.25
  • HBIO $2.50
  • AVG Volume (30 Days)
  • VVOS 140.4K
  • HBIO 478.9K
  • Earning Date
  • VVOS 11-13-2025
  • HBIO 11-06-2025
  • Dividend Yield
  • VVOS N/A
  • HBIO N/A
  • EPS Growth
  • VVOS N/A
  • HBIO N/A
  • EPS
  • VVOS N/A
  • HBIO N/A
  • Revenue
  • VVOS $14,393,000.00
  • HBIO $88,750,000.00
  • Revenue This Year
  • VVOS $3.83
  • HBIO N/A
  • Revenue Next Year
  • VVOS $25.27
  • HBIO $7.13
  • P/E Ratio
  • VVOS N/A
  • HBIO N/A
  • Revenue Growth
  • VVOS 2.65
  • HBIO N/A
  • 52 Week Low
  • VVOS $1.98
  • HBIO $0.28
  • 52 Week High
  • VVOS $7.95
  • HBIO $3.04
  • Technical
  • Relative Strength Index (RSI)
  • VVOS 35.25
  • HBIO 41.24
  • Support Level
  • VVOS $3.80
  • HBIO $0.49
  • Resistance Level
  • VVOS $4.63
  • HBIO $0.47
  • Average True Range (ATR)
  • VVOS 0.40
  • HBIO 0.03
  • MACD
  • VVOS -0.09
  • HBIO -0.01
  • Stochastic Oscillator
  • VVOS 0.60
  • HBIO 8.29

About VVOS Vivos Therapeutics Inc.

Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.

About HBIO Harvard Bioscience Inc.

Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, pharmaceutical and therapy discovery, bioproduction, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, and Panlab. The majority of its revenue comes from the United States.

Share on Social Networks: